Targeting the cardiovascular system with sitagliptin improves diastolic cardiac function but does not improve cardiorespiratory fitness in adults with type 2 diabetes

BACKGROUND. People with type 2 diabetes mellitus (T2D) have preclinical cardiac and vascular dysfunction that predicts low cardiorespiratory fitness (CRF). CRF is a powerful predictor of cardiovascular mortality, a primary concern in T2D management. Glucagon-like pepetide-1 (GLP-1) augments cardiova...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Diabetes Complications
Hlavní autoři: Scalzo, Rebecca L., Rafferty, Deirdre, Schauer, Irene, Huebschmann, Amy G., Cree-Green, Melanie, Reusch, Jane E.B., Regensteiner, Judith G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278036/
https://ncbi.nlm.nih.gov/pubmed/31182338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2019.05.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky